Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$465M |
| 2 |
Microsoft
MSFT
|
+$373M |
| 3 |
Amazon
AMZN
|
+$274M |
| 4 |
ExxonMobil
XOM
|
+$253M |
| 5 |
Meta Platforms (Facebook)
META
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$249M |
| 2 |
STJ
St Jude Medical
STJ
|
+$203M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$156M |
| 4 |
HAR
Harman International Industries
HAR
|
+$71.2M |
| 5 |
CSC
Computer Sciences
CSC
|
+$56.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.77% |
| 2 | Financials | 15.74% |
| 3 | Healthcare | 13.31% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Qualys
QLYS
$6.47B
| $9.3M | ﹤0.01% |
245,420
+29,874
| +14% | +$1.05M |
|
1652
Agnico Eagle Mines
AEM
$91.7B
| $9.29M | ﹤0.01% |
+219,600
| New | +$9.87M |
|
1653
Tronox
TROX
$1.03B
| $9.28M | ﹤0.01% |
503,143
+41,532
| +9% | +$617K |
|
|
CYS
1654
DELISTED
CYS Investments Inc.
CYS
| $9.28M | ﹤0.01% |
1,167,557
+38,078
| +3% | +$298K |
|
|
ACOR
1655
DELISTED
Acorda Therapeutics
ACOR
| $9.26M | ﹤0.01% |
3,674
+276
| +8% | +$794K |
|
|
CUDA
1656
DELISTED
Barracuda Networks, Inc.
CUDA
| $9.25M | ﹤0.01% |
400,240
+124,889
| +45% | +$2.92M |
|
|
VSTO
1657
DELISTED
Vista Outdoor Inc.
VSTO
| $9.23M | ﹤0.01% |
448,259
+16,369
| +4% | +$405K |
|
1658
Badger Meter
BMI
$3.97B
| $9.22M | ﹤0.01% |
251,009
+7,278
| +3% | +$268K |
|
1659
MiMedx Group
MDXG
$625M
| $9.22M | ﹤0.01% |
967,302
+43,591
| +5% | +$368K |
|
1660
TherapeuticsMD
TXMD
$24.2M
| $9.21M | ﹤0.01% |
25,592
+2,353
| +10% | +$728K |
|
|
HMHC
1661
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $9.21M | ﹤0.01% |
907,299
+36,783
| +4% | +$385K |
|
1662
Corcept Therapeutics
CORT
$12.2B
| $9.21M | ﹤0.01% |
840,195
+77,945
| +10% | +$685K |
|
1663
Emergent Biosolutions
EBS
$228M
| $9.12M | ﹤0.01% |
314,198
+25,953
| +9% | +$790K |
|
1664
Lakeland Financial Corp
LKFN
$1.54B
| $9.12M | ﹤0.01% |
211,517
+7,437
| +4% | +$332K |
|
1665
Atkore
ATKR
$3.17B
| $9.12M | ﹤0.01% |
346,880
+134,284
| +63% | +$3.46M |
|
1666
Rayonier Advanced Materials
RYAM
$583M
| $9.11M | ﹤0.01% |
677,482
+58,386
| +9% | +$820K |
|
1667
Planet Fitness
PLNT
$3.64B
| $9.11M | ﹤0.01% |
472,614
+147,602
| +45% | +$3.05M |
|
|
FCH
1668
DELISTED
Felcor Lodging Trust
FCH
| $9.08M | ﹤0.01% |
1,209,333
+86,387
| +8% | +$655K |
|
1669
First Commonwealth Financial
FCF
$2.18B
| $9.07M | ﹤0.01% |
684,206
-11,926
| -2% | -$165K |
|
1670
Open Text
OTEX
$5.84B
| $9.07M | ﹤0.01% |
267,636
+155,886
| +139% | +$5.18M |
|
1671
CareTrust REIT
CTRE
$9.21B
| $9.03M | ﹤0.01% |
537,109
+42,974
| +9% | +$667K |
|
|
PMT
1672
PennyMac Mortgage Investment
PMT
$829M
| $9.03M | ﹤0.01% |
508,971
+13,757
| +3% | +$233K |
|
1673
Clearway Energy Class C
CWEN
$7.06B
| $9.02M | ﹤0.01% |
509,714
+8,836
| +2% | +$150K |
|
|
PNK
1674
DELISTED
Pinnacle Entertainment Inc.
PNK
| $9.02M | ﹤0.01% |
461,987
+15,527
| +3% | +$256K |
|
|
GBT
1675
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $9.02M | ﹤0.01% |
244,667
+91,498
| +60% | +$2.3M |
|
Similar funds
Geode Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Geode Capital Management held 4,180 positions worth $244B, up 13% from $215B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management deployed $16.9B of net new capital in Q1 2017, opening 139 new positions and adding to 3,365 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 786,074 shares worth $42.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Computer Sciences, an estimated $56.7M trimmed.
- Geode Capital Management's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 786,074 shares worth $42.8M.
- Geode Capital Management added most to Apple in Q1 2017, an estimated $465M increase.
- Geode Capital Management's biggest Q1 2017 reduction was Computer Sciences, cutting an estimated $56.7M.
- Geode Capital Management fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $249M.
- Geode Capital Management's ten largest holdings make up 16% of its $244B portfolio in Q1 2017.
- Geode Capital Management opened 139 new positions and closed 111 in Q1 2017.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $244B.
Based on Geode Capital Management's 13F filing for Q1 2017, filed 12 May 2017.